ACRIVON THERAPEUTICS, INC.

Insiders Acrivon Therapeutics, Inc.

Equities

ACRV

US0048901096

Market Closed - Nasdaq Other stock markets 01:30:00 15/06/2024 am IST			5-day change	1st Jan Change
7.25 ^USD	-6.09%		0.00%	+47.36%

14/05	Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	North American Morning Briefing : More Earnings -2-	DJ

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Acrivon Therapeutics, Inc. Appoints Santhosh Palani to its Board of Directors	04/03	CI
Acrivon Therapeutics, Inc. Appoints Ivana Magovcevic-Liebisch to its Board of Directors	08/02	CI
Acrivon Therapeutics Names Jean-Marie Cuillerot as Chief Medical Officer	04/01	MT
Acrivon Therapeutics, Inc. Announces Management Changes	03/01	CI
Acrivon Therapeutics Announces the Appointment of Adam Levy as Senior Vice President and Head, Investor Relations and Corporate Affairs	20/23/20	CI
Acrivon Therapeutics, Inc. Appoints Charles Baum as Board of Directors	23/23/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer